CeaproTSXV: CZO

Ceapro creates organic products line

· Issued by Ceapro via CNW

EDMONTON, May 30 /CNW/ - Ceapro Inc. (CZO - TSX Venture) announces the development of Ceapro Organic(TM), a line of premium personal care active ingredients based on organically grown and certified extracts. The line is targeted at niche markets in North America, Europe, and Asia.

Said Ceapro President and CEO, Dr Mark Redmond, "The new product range captures the health benefits of plants cultivated using 'green' farming practices, an important untapped market for Ceapro. We expect to capitalize on the growing consumer desire for products that are kind to both their skin and the environment."

The Ceapro Organic(TM) range includes products for detoxifying, calming and moisturizing, smoothing, revitalizing and deep cleansing. According to TNS Media Intelligence/CMR, the natural/organic skincare, haircare and cosmetics market is expected to reach $5.8 billion by 2008, expanding significantly from about $3.9 billion in 2003. Similarly, Organic Monitor, a UK-based business research and consulting company, reported the European organic cosmeceutical market is worth Euro 1 billion.

Though Ceapro is currently supplying directly to select customers, a distribution network is under development involving independent distributors in each of several target countries including Korea and the United Kingdom. Formal distribution agreements in France and the USA are expected shortly.

The new line expands into particular high-end, organic markets, so will complement Ceapro's current sales. Almost doubling Ceapro's existing product range of six active ingredients, Ceapro Organic(TM) products are:

1.  CEAPRO ICE, Certified Organic Cold Extract of Oat

2.  CEAPRO GOLD, Certified Organic Extract of Oat

3.  CEAPRO MAXIMUM COLLOIDAL OATMEAL, Certified Organic Colloidal Oatmeal

4.  CEAPRO OAT EXFOLIANT, Certified Organic Hulls of Oat

5.  CEAPRO LUPINE PROTEIN, Sweet Lupine Flour

About Ceapro Inc.

Ceapro Inc is a Canadian growth-stage biotechnology company. Ceapro's core technology is the extraction of functional, active ingredients from plants and other renewable resources. We add further value to our extracts by manufacturing medical and therapeutic products, and by supporting the use of our extracts in products for human and animal health. We have also introduced health and wellness services employing our CeaProve(R) diagnostic technology. Our most recent initiative is the creation of Ceapro BioEnergy Inc. (CBE), a wholly-owned subsidiary to utilize Ceapro's proprietary technology for the production of ethanol and value-added products. Ceapro shares trade on the Canadian TSX Venture Exchange under the symbol CZO. To learn more about Ceapro, visit our website at www.ceapro.com.

The TSX has neither approved nor disapproved of the information contained

herein -

This release may contain forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

%SEDAR: 00010110E

Ceapro on 6ix

Earlier from Ceapro

Later from Ceapro

All Ceapro news releases